tert-Butyl ((1-(6-methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-yl)methyl)carbamate

Catalog No. :
ACZVHN654
CAS No. :
1353958-76-5
Molecular Formula :
C17H28N4O3S
Molecular Weight :
368.50

IUPAC Name:tert-butyl ((1-(6-methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-yl)methyl)carbamate

tert-Butyl ((1-(6-methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-yl)methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$89.00Login to see priceInquiryInquiry
250mg95%$150.00Login to see priceInquiryInquiry
1g95%$480.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((1-(6-methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-yl)methyl)carbamate
IUPAC Nametert-butyl ((1-(6-methoxy-2-(methylthio)pyrimidin-4-yl)piperidin-4-yl)methyl)carbamate
Molecular FormulaC17H28N4O3S
Molecular Weight368.50
SMILESO=C(OC(C)(C)C)NCC1CCN(C2=NC(SC)=NC(OC)=C2)CC1
InChI KeyMZVMWFOCKMGZNG-UHFFFAOYSA-N
Synonymtert-Butyl ((1-(6-Methoxy-2-(Methylthio)pyriMidin-4-yl)piperidin-4-yl)Methyl)carbaMate;Carbamic acid, N-[[1-[6-methoxy-2-(methylthio)-4-pyrimidinyl]-4-piperidinyl]methyl]-, 1,1-dimethylethyl ester
CAS No.1353958-76-5

Synthetic Route by SureRoute

1. ACZVHN654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKBE041 route compound structure diagram
    ACNKBE041135632-53-0 In Stock
  2. Plus
  3. ACUPJB596 route compound structure diagram
    ACUPJB59689466-42-2 In Stock
  4. Then
  5. ACZVHN654 route product structure diagram
    ACZVHN6541353958-76-5
Inquiry

2. ACZVHN654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACZVHN654 route product structure diagram
    ACZVHN6541353958-76-5
Inquiry

Comments (0)